Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urogenital Neoplasms × Practice Guidelines as Topic × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Neoplasms 2 Colorectal Neoplasms 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Radiodermatitis 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lung Neoplasms 1 Localized Prostate Carcinoma 1 Leukemia, Myeloid, Acute 1 Hepatitis B 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Disease Progression 1 Digestive System Carcinoma 1 Communication 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 2 Paclitaxel 2 valrubicin 1 temsirolimus 1 sipuleucel-T 1 luprolide acetate gel depot 1 ferumoxtran-10 1 abiraterone 1 abemaciclib 1 Suspensions 1 Surveys and Questionnaires 1 Standard of Care 1 Radiotherapy 1 Prednisone 1 Prednisolone 1 Powders 1 Pemetrexed 1 Neoadjuvant Therapy 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Educational Status 1 Docetaxel 1 Bevacizumab 1 Administration, Intravesical 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡